An economic evaluation of vector control in the age of a dengue vaccine.

ABSTRACT:

Introduction

Dengue is a rapidly emerging vector-borne Neglected Tropical Disease, with a 30-fold increase in the number of cases reported since 1960. The economic cost of the illness is measured in the billions of dollars annually. Environmental change and unplanned urbanization are conspiring to raise the health and economic cost even further beyond the reach of health systems and households. The health-sector response has depended in large part on control of the Aedes aegypti and Ae. albopictus (mosquito) vectors. The cost-effectiveness of the first-ever dengue vaccine remains to be evaluated in the field. In this paper, we examine how it might affect the cost-effectiveness of sustained vector control.

Methods

We employ a dynamic Markov model of the effects of vector cont

SUBMITTER: Fitzpatrick C 

PROVIDER: S-EPMC5573582 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature